APO Research
Talk to an analyst

APO RESEARCH · REPORT

High Blood Pressure Drugs (Hypertension)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global High Blood Pressure Drugs (Hypertension) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025190 pages

Choose your research edition.

Industry ResearchHigh Blood Pressure Drugs (Hypertension) Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal High Blood Pressure Drugs (Hypertension) Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal High Blood Pressure Drugs (Hypertension) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal High Blood Pressure Drugs (Hypertension) Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal High Blood Pressure Drugs (Hypertension) Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global High Blood Pressure Drugs (Hypertension) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for High Blood Pressure Drugs (Hypertension) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for High Blood Pressure Drugs (Hypertension) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for High Blood Pressure Drugs (Hypertension) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for High Blood Pressure Drugs (Hypertension) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of High Blood Pressure Drugs (Hypertension) include Alvogen, Boryung, Lung Biotechnology, Reata Pharmaceuticals, Symplmed, Yuhan, Bayer, Pfizer and Eli Lilly, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global High Blood Pressure Drugs (Hypertension) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of High Blood Pressure Drugs (Hypertension) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents High Blood Pressure Drugs (Hypertension) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the High Blood Pressure Drugs (Hypertension) market size, projected growth trends, production technologies, key applications, and end-use industries.

High Blood Pressure Drugs (Hypertension) Segment by Company

Alvogen

Boryung

Lung Biotechnology

Reata Pharmaceuticals

Symplmed

Yuhan

Bayer

Pfizer

Eli Lilly

Merck

Novartis

Sanofi

Takeda

High Blood Pressure Drugs (Hypertension) Segment by Type

ACEI

ARB

CCB

High Blood Pressure Drugs (Hypertension) Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

High Blood Pressure Drugs (Hypertension) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global High Blood Pressure Drugs (Hypertension) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of High Blood Pressure Drugs (Hypertension) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of High Blood Pressure Drugs (Hypertension).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the High Blood Pressure Drugs (Hypertension) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of High Blood Pressure Drugs (Hypertension) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of High Blood Pressure Drugs (Hypertension) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of High Blood Pressure Drugs (Hypertension) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. High Blood Pressure Drugs (Hypertension) Industry Trends Table 2. High Blood Pressure Drugs (Hypertension) Industry Drivers Table 3. High Blood Pressure Drugs (Hypertension) Industry Opportunities and Challenges Table 4. High Blood Pressure Drugs (Hypertension) Industry Restraints Table 5. Global High Blood Pressure Drugs (Hypertension) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global High Blood Pressure Drugs (Hypertension) Sales by Manufacturers (K Tons) & (2021-2026) Table 8. Global High Blood Pressure Drugs (Hypertension) Sales Market Share by Manufacturers Table 9. Global High Blood Pressure Drugs (Hypertension) Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global High Blood Pressure Drugs (Hypertension) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global High Blood Pressure Drugs (Hypertension) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global High Blood Pressure Drugs (Hypertension) Manufacturers, Product Type & Application Table 13. Global High Blood Pressure Drugs (Hypertension) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global High Blood Pressure Drugs (Hypertension) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of ACEI Table 17. Major Manufacturers of ARB Table 18. Major Manufacturers of CCB Table 19. Global High Blood Pressure Drugs (Hypertension) Sales by Type 2021 VS 2025 VS 2032 (K Tons) Table 20. Global High Blood Pressure Drugs (Hypertension) Sales by Type (2021-2026) & (K Tons) Table 21. Global High Blood Pressure Drugs (Hypertension) Sales by Type (2027-2032) & (K Tons) Table 22. Global High Blood Pressure Drugs (Hypertension) Sales Market Share by Type (2021-2026) Table 23. Global High Blood Pressure Drugs (Hypertension) Sales Market Share by Type (2027-2032) Table 24. Global High Blood Pressure Drugs (Hypertension) Revenue by Type 2021 VS 2025 VS 2032 (K Tons) Table 25. Global High Blood Pressure Drugs (Hypertension) Revenue by Type (2021-2026) & (K Tons) Table 26. Global High Blood Pressure Drugs (Hypertension) Revenue by Type (2027-2032) & (K Tons) Table 27. Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Type (2021-2026) Table 28. Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Retail Pharmacy Table 30. Major Manufacturers of Online Pharmacy Table 31. Major Manufacturers of Hospital Pharmacy Table 32. Global High Blood Pressure Drugs (Hypertension) Sales by Application 2021 VS 2025 VS 2032 (K Tons) Table 33. Global High Blood Pressure Drugs (Hypertension) Sales by Application (2021-2026) & (K Tons) Table 34. Global High Blood Pressure Drugs (Hypertension) Sales by Application (2027-2032) & (K Tons) Table 35. Global High Blood Pressure Drugs (Hypertension) Sales Market Share by Application (2021-2026) Table 36. Global High Blood Pressure Drugs (Hypertension) Sales Market Share by Application (2027-2032) Table 37. Global High Blood Pressure Drugs (Hypertension) Revenue by Application 2021 VS 2025 VS 2032 (K Tons) Table 38. Global High Blood Pressure Drugs (Hypertension) Revenue by Application (2021-2026) & (K Tons) Table 39. Global High Blood Pressure Drugs (Hypertension) Revenue by Application (2027-2032) & (K Tons) Table 40. Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Application (2021-2026) Table 41. Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Application (2027-2032) Table 42. Global High Blood Pressure Drugs (Hypertension) Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Table 43. Global High Blood Pressure Drugs (Hypertension) Sales by Region (2021-2026) & (K Tons) Table 44. Global High Blood Pressure Drugs (Hypertension) Sales Market Share by Region (2021-2026) Table 45. Global High Blood Pressure Drugs (Hypertension) Sales Forecasted by Region (2027-2032) & (K Tons) Table 46. Global High Blood Pressure Drugs (Hypertension) Sales Forecasted Market Share by Region (2027-2032) Table 47. North America High Blood Pressure Drugs (Hypertension) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 48. North America High Blood Pressure Drugs (Hypertension) Sales by Country (2021-2026) & (K Tons) Table 49. North America High Blood Pressure Drugs (Hypertension) Sales by Country (2027-2032) & (K Tons) Table 50. Europe High Blood Pressure Drugs (Hypertension) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 51. Europe High Blood Pressure Drugs (Hypertension) Sales by Country (2021-2026) & (K Tons) Table 52. Europe High Blood Pressure Drugs (Hypertension) Sales by Country (2027-2032) & (K Tons) Table 53. Asia Pacific High Blood Pressure Drugs (Hypertension) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 54. Asia Pacific High Blood Pressure Drugs (Hypertension) Sales by Country (2021-2026) & (K Tons) Table 55. Asia Pacific High Blood Pressure Drugs (Hypertension) Sales by Country (2027-2032) & (K Tons) Table 56. South America, Middle East and Africa High Blood Pressure Drugs (Hypertension) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 57. South America, Middle East and Africa High Blood Pressure Drugs (Hypertension) Sales by Country (2021-2026) & (K Tons) Table 58. South America, Middle East and Africa High Blood Pressure Drugs (Hypertension) Sales by Country (2027-2032) & (K Tons) Table 59. Global High Blood Pressure Drugs (Hypertension) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global High Blood Pressure Drugs (Hypertension) Revenue by Region (2021-2026) & (US$ Million) Table 61. Global High Blood Pressure Drugs (Hypertension) Revenue by Region (2027-2032) & (US$ Million) Table 62. Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Region (2021-2026) Table 63. Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Region (2027-2032) Table 64. Alvogen Company Information Table 65. Alvogen Business Overview Table 66. Alvogen High Blood Pressure Drugs (Hypertension) Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Alvogen High Blood Pressure Drugs (Hypertension) Product Portfolio Table 68. Alvogen Recent Development Table 69. Boryung Company Information Table 70. Boryung Business Overview Table 71. Boryung High Blood Pressure Drugs (Hypertension) Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Boryung High Blood Pressure Drugs (Hypertension) Product Portfolio Table 73. Boryung Recent Development Table 74. Lung Biotechnology Company Information Table 75. Lung Biotechnology Business Overview Table 76. Lung Biotechnology High Blood Pressure Drugs (Hypertension) Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Lung Biotechnology High Blood Pressure Drugs (Hypertension) Product Portfolio Table 78. Lung Biotechnology Recent Development Table 79. Reata Pharmaceuticals Company Information Table 80. Reata Pharmaceuticals Business Overview Table 81. Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Product Portfolio Table 83. Reata Pharmaceuticals Recent Development Table 84. Symplmed Company Information Table 85. Symplmed Business Overview Table 86. Symplmed High Blood Pressure Drugs (Hypertension) Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Symplmed High Blood Pressure Drugs (Hypertension) Product Portfolio Table 88. Symplmed Recent Development Table 89. Yuhan Company Information Table 90. Yuhan Business Overview Table 91. Yuhan High Blood Pressure Drugs (Hypertension) Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Yuhan High Blood Pressure Drugs (Hypertension) Product Portfolio Table 93. Yuhan Recent Development Table 94. Bayer Company Information Table 95. Bayer Business Overview Table 96. Bayer High Blood Pressure Drugs (Hypertension) Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Bayer High Blood Pressure Drugs (Hypertension) Product Portfolio Table 98. Bayer Recent Development Table 99. Pfizer Company Information Table 100. Pfizer Business Overview Table 101. Pfizer High Blood Pressure Drugs (Hypertension) Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Pfizer High Blood Pressure Drugs (Hypertension) Product Portfolio Table 103. Pfizer Recent Development Table 104. Eli Lilly Company Information Table 105. Eli Lilly Business Overview Table 106. Eli Lilly High Blood Pressure Drugs (Hypertension) Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Eli Lilly High Blood Pressure Drugs (Hypertension) Product Portfolio Table 108. Eli Lilly Recent Development Table 109. Merck Company Information Table 110. Merck Business Overview Table 111. Merck High Blood Pressure Drugs (Hypertension) Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Merck High Blood Pressure Drugs (Hypertension) Product Portfolio Table 113. Merck Recent Development Table 114. Novartis Company Information Table 115. Novartis Business Overview Table 116. Novartis High Blood Pressure Drugs (Hypertension) Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Novartis High Blood Pressure Drugs (Hypertension) Product Portfolio Table 118. Novartis Recent Development Table 119. Sanofi Company Information Table 120. Sanofi Business Overview Table 121. Sanofi High Blood Pressure Drugs (Hypertension) Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Sanofi High Blood Pressure Drugs (Hypertension) Product Portfolio Table 123. Sanofi Recent Development Table 124. Takeda Company Information Table 125. Takeda Business Overview Table 126. Takeda High Blood Pressure Drugs (Hypertension) Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Takeda High Blood Pressure Drugs (Hypertension) Product Portfolio Table 128. Takeda Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. High Blood Pressure Drugs (Hypertension) Distributors List Table 132. High Blood Pressure Drugs (Hypertension) Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. High Blood Pressure Drugs (Hypertension) Product Image Figure 2. Global High Blood Pressure Drugs (Hypertension) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global High Blood Pressure Drugs (Hypertension) Market Size (2021-2032) & (US$ Million) Figure 4. Global High Blood Pressure Drugs (Hypertension) Sales (2021-2032) & (K Tons) Figure 5. Global High Blood Pressure Drugs (Hypertension) Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 High Blood Pressure Drugs (Hypertension) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. ACEI Image Figure 9. ARB Image Figure 10. CCB Image Figure 11. Global High Blood Pressure Drugs (Hypertension) Sales by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 12. Global High Blood Pressure Drugs (Hypertension) Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global High Blood Pressure Drugs (Hypertension) Sales Market Share by Type (2021-2032) Figure 14. Global High Blood Pressure Drugs (Hypertension) Revenue by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 15. Global High Blood Pressure Drugs (Hypertension) Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Type (2021-2032) Figure 17. Retail Pharmacy Image Figure 18. Online Pharmacy Image Figure 19. Hospital Pharmacy Image Figure 20. Global High Blood Pressure Drugs (Hypertension) Sales by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 21. Global High Blood Pressure Drugs (Hypertension) Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global High Blood Pressure Drugs (Hypertension) Sales Market Share by Application (2021-2032) Figure 23. Global High Blood Pressure Drugs (Hypertension) Revenue by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 24. Global High Blood Pressure Drugs (Hypertension) Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Application (2021-2032) Figure 26. North America High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 27. North America High Blood Pressure Drugs (Hypertension) Sales Market Share by Country (2021-2032) Figure 28. U.S. High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 29. Canada High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 30. Mexico High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 31. Europe High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 32. Europe High Blood Pressure Drugs (Hypertension) Sales Market Share by Country (2021-2032) Figure 33. Germany High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 34. France High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 35. U.K. High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 36. Italy High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 37. Netherlands High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 38. Asia Pacific High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 39. Asia Pacific High Blood Pressure Drugs (Hypertension) Sales Market Share by Country (2021-2032) Figure 40. China High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 41. Japan High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 42. South Korea High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 43. Southeast Asia High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 44. India High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 45. Australia High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 46. South America, Middle East and Africa High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 47. South America, Middle East and Africa High Blood Pressure Drugs (Hypertension) Sales Market Share by Country (2021-2032) Figure 48. Brazil High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 49. South Africa High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 50. Saudi Arabia High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 51. Turkey High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 52. Argentina High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 53. UAE High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 54. Egypt High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 55. Chile High Blood Pressure Drugs (Hypertension) Sales and Growth Rate (2021-2032) & (K Tons) Figure 56. Global High Blood Pressure Drugs (Hypertension) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America High Blood Pressure Drugs (Hypertension) Revenue (2021-2032) & (US$ Million) Figure 59. North America High Blood Pressure Drugs (Hypertension) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe High Blood Pressure Drugs (Hypertension) Revenue (2021-2032) & (US$ Million) Figure 61. Europe High Blood Pressure Drugs (Hypertension) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific High Blood Pressure Drugs (Hypertension) Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific High Blood Pressure Drugs (Hypertension) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa High Blood Pressure Drugs (Hypertension) Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa High Blood Pressure Drugs (Hypertension) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. High Blood Pressure Drugs (Hypertension) Value Chain Figure 67. Manufacturing Cost Structure Figure 68. High Blood Pressure Drugs (Hypertension) Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • ACEI
  • ARB
  • CCB
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
Companies covered
  • Alvogen
  • Boryung
  • Lung Biotechnology
  • Reata Pharmaceuticals
  • Symplmed
  • Yuhan
  • Bayer
  • Pfizer
  • Eli Lilly
  • Merck
  • Novartis
  • Sanofi
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global High Blood Pressure Drugs (Hypertension) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global High Blood Pressure Drugs (Hypertension) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global High Blood Pressure Drugs (Hypertension) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global High Blood Pressure Drugs (Hypertension) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global High Blood Pressure Drugs (Hypertension) Market Dynamics
  1. 2.1 High Blood Pressure Drugs (Hypertension) Industry Trends
  2. 2.2 High Blood Pressure Drugs (Hypertension) Industry Drivers
  3. 2.3 High Blood Pressure Drugs (Hypertension) Industry Opportunities and Challenges
  4. 2.4 High Blood Pressure Drugs (Hypertension) Industry Restraints
3 High Blood Pressure Drugs (Hypertension) Market by Manufacturers
  1. 3.1 Global High Blood Pressure Drugs (Hypertension) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global High Blood Pressure Drugs (Hypertension) Sales by Manufacturers (2021-2026)
  3. 3.3 Global High Blood Pressure Drugs (Hypertension) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global High Blood Pressure Drugs (Hypertension) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global High Blood Pressure Drugs (Hypertension) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global High Blood Pressure Drugs (Hypertension) Manufacturers, Product Type & Application
  7. 3.7 Global High Blood Pressure Drugs (Hypertension) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global High Blood Pressure Drugs (Hypertension) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 High Blood Pressure Drugs (Hypertension) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 High Blood Pressure Drugs (Hypertension) Tier 1, Tier 2, and Tier 3
4 High Blood Pressure Drugs (Hypertension) Market by Type
  1. 4.1 High Blood Pressure Drugs (Hypertension) Type Introduction
  2. 4.1.1 ACEI
  3. 4.1.2 ARB
  4. 4.1.3 CCB
  5. 4.2 Global High Blood Pressure Drugs (Hypertension) Sales by Type
  6. 4.2.1 Global High Blood Pressure Drugs (Hypertension) Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global High Blood Pressure Drugs (Hypertension) Sales by Type (2021-2032)
  8. 4.2.3 Global High Blood Pressure Drugs (Hypertension) Sales Market Share by Type (2021-2032)
  9. 4.3 Global High Blood Pressure Drugs (Hypertension) Revenue by Type
  10. 4.3.1 Global High Blood Pressure Drugs (Hypertension) Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global High Blood Pressure Drugs (Hypertension) Revenue by Type (2021-2032)
  12. 4.3.3 Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Type (2021-2032)
5 High Blood Pressure Drugs (Hypertension) Market by Application
  1. 5.1 High Blood Pressure Drugs (Hypertension) Application Introduction
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Hospital Pharmacy
  5. 5.2 Global High Blood Pressure Drugs (Hypertension) Sales by Application
  6. 5.2.1 Global High Blood Pressure Drugs (Hypertension) Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global High Blood Pressure Drugs (Hypertension) Sales by Application (2021-2032)
  8. 5.2.3 Global High Blood Pressure Drugs (Hypertension) Sales Market Share by Application (2021-2032)
  9. 5.3 Global High Blood Pressure Drugs (Hypertension) Revenue by Application
  10. 5.3.1 Global High Blood Pressure Drugs (Hypertension) Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global High Blood Pressure Drugs (Hypertension) Revenue by Application (2021-2032)
  12. 5.3.3 Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Application (2021-2032)
6 Global High Blood Pressure Drugs (Hypertension) Sales by Region
  1. 6.1 Global High Blood Pressure Drugs (Hypertension) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global High Blood Pressure Drugs (Hypertension) Sales by Region (2021-2032)
  3. 6.2.1 Global High Blood Pressure Drugs (Hypertension) Sales by Region (2021-2026)
  4. 6.2.2 Global High Blood Pressure Drugs (Hypertension) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America High Blood Pressure Drugs (Hypertension) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America High Blood Pressure Drugs (Hypertension) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe High Blood Pressure Drugs (Hypertension) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe High Blood Pressure Drugs (Hypertension) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific High Blood Pressure Drugs (Hypertension) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific High Blood Pressure Drugs (Hypertension) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa High Blood Pressure Drugs (Hypertension) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa High Blood Pressure Drugs (Hypertension) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global High Blood Pressure Drugs (Hypertension) Revenue by Region
  1. 7.1 Global High Blood Pressure Drugs (Hypertension) Revenue by Region
  2. 7.1.1 Global High Blood Pressure Drugs (Hypertension) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global High Blood Pressure Drugs (Hypertension) Revenue by Region (2021-2026)
  4. 7.1.3 Global High Blood Pressure Drugs (Hypertension) Revenue by Region (2027-2032)
  5. 7.1.4 Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America High Blood Pressure Drugs (Hypertension) Revenue (2021-2032)
  8. 7.2.2 North America High Blood Pressure Drugs (Hypertension) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe High Blood Pressure Drugs (Hypertension) Revenue (2021-2032)
  11. 7.3.2 Europe High Blood Pressure Drugs (Hypertension) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific High Blood Pressure Drugs (Hypertension) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific High Blood Pressure Drugs (Hypertension) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa High Blood Pressure Drugs (Hypertension) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa High Blood Pressure Drugs (Hypertension) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Alvogen
  2. 8.1.1 Alvogen Company Information
  3. 8.1.2 Alvogen Business Overview
  4. 8.1.3 Alvogen High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Alvogen High Blood Pressure Drugs (Hypertension) Product Portfolio
  6. 8.1.5 Alvogen Recent Developments
  7. 8.2 Boryung
  8. 8.2.1 Boryung Company Information
  9. 8.2.2 Boryung Business Overview
  10. 8.2.3 Boryung High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boryung High Blood Pressure Drugs (Hypertension) Product Portfolio
  12. 8.2.5 Boryung Recent Developments
  13. 8.3 Lung Biotechnology
  14. 8.3.1 Lung Biotechnology Company Information
  15. 8.3.2 Lung Biotechnology Business Overview
  16. 8.3.3 Lung Biotechnology High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Lung Biotechnology High Blood Pressure Drugs (Hypertension) Product Portfolio
  18. 8.3.5 Lung Biotechnology Recent Developments
  19. 8.4 Reata Pharmaceuticals
  20. 8.4.1 Reata Pharmaceuticals Company Information
  21. 8.4.2 Reata Pharmaceuticals Business Overview
  22. 8.4.3 Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Product Portfolio
  24. 8.4.5 Reata Pharmaceuticals Recent Developments
  25. 8.5 Symplmed
  26. 8.5.1 Symplmed Company Information
  27. 8.5.2 Symplmed Business Overview
  28. 8.5.3 Symplmed High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Symplmed High Blood Pressure Drugs (Hypertension) Product Portfolio
  30. 8.5.5 Symplmed Recent Developments
  31. 8.6 Yuhan
  32. 8.6.1 Yuhan Company Information
  33. 8.6.2 Yuhan Business Overview
  34. 8.6.3 Yuhan High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Yuhan High Blood Pressure Drugs (Hypertension) Product Portfolio
  36. 8.6.5 Yuhan Recent Developments
  37. 8.7 Bayer
  38. 8.7.1 Bayer Company Information
  39. 8.7.2 Bayer Business Overview
  40. 8.7.3 Bayer High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bayer High Blood Pressure Drugs (Hypertension) Product Portfolio
  42. 8.7.5 Bayer Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer High Blood Pressure Drugs (Hypertension) Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 Eli Lilly
  50. 8.9.1 Eli Lilly Company Information
  51. 8.9.2 Eli Lilly Business Overview
  52. 8.9.3 Eli Lilly High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Eli Lilly High Blood Pressure Drugs (Hypertension) Product Portfolio
  54. 8.9.5 Eli Lilly Recent Developments
  55. 8.10 Merck
  56. 8.10.1 Merck Company Information
  57. 8.10.2 Merck Business Overview
  58. 8.10.3 Merck High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Merck High Blood Pressure Drugs (Hypertension) Product Portfolio
  60. 8.10.5 Merck Recent Developments
  61. 8.11 Novartis
  62. 8.11.1 Novartis Company Information
  63. 8.11.2 Novartis Business Overview
  64. 8.11.3 Novartis High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Novartis High Blood Pressure Drugs (Hypertension) Product Portfolio
  66. 8.11.5 Novartis Recent Developments
  67. 8.12 Sanofi
  68. 8.12.1 Sanofi Company Information
  69. 8.12.2 Sanofi Business Overview
  70. 8.12.3 Sanofi High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Sanofi High Blood Pressure Drugs (Hypertension) Product Portfolio
  72. 8.12.5 Sanofi Recent Developments
  73. 8.13 Takeda
  74. 8.13.1 Takeda Company Information
  75. 8.13.2 Takeda Business Overview
  76. 8.13.3 Takeda High Blood Pressure Drugs (Hypertension) Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Takeda High Blood Pressure Drugs (Hypertension) Product Portfolio
  78. 8.13.5 Takeda Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 High Blood Pressure Drugs (Hypertension) Value Chain Analysis
  2. 9.1.1 High Blood Pressure Drugs (Hypertension) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 High Blood Pressure Drugs (Hypertension) Production Mode & Process
  6. 9.2 High Blood Pressure Drugs (Hypertension) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 High Blood Pressure Drugs (Hypertension) Distributors
  9. 9.2.3 High Blood Pressure Drugs (Hypertension) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst